Rob Brainin Email and Phone Number
Rob Brainin work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Rob Brainin personal email
Rob Brainin phone numbers
GLOBAL LIFE SCIENCES/HEALTHCARE EXECUTIVE AND BOARD DIRECTORI am a global life sciences and healthcare executive and board director with a passion for using technology and molecular data to improve people’s lives. This passion has fueled a track record of leading businesses to consistently meet and exceed financial and other objectives. I bring the ability to grow and scale companies across a variety of businesses and markets within the life sciences tools, technologies, and data insight segments. The approach I utilize relies on marrying a customer segment's unmet needs with a company’s technologies in a way that is profitable:Step 1: Identify the most attractive opportunities for growth Step 2: Harmonize the vision, strategy and execution of the company by aligning the Board, C-suite, executive team, and employee population toward the same set of primary objectivesStep 3: Build and partner with a strong, collaborative leadership team to executeStep 4: Ensure that the right measurement systems are in place to track progress against our goals. I have applied this approach in a number of senior executive roles, currently at Veracyte as Chief Business Officer, and recently at Genuity Science as the CEO focusing on utilizing the intersection of molecular data and data science (including AI) to derive genomic data insights. These insights enabled us to collaborate with biotech and pharmaceutical companies to accelerate their drug discovery and development efforts. I utilized a variation of this playbook at Illumina leading the Life Sciences & Applied Genomics business, and before that as an executive and general manager at Life Technologies/Thermo Fisher where I led a number of different business units including cell culture, enterprise genomics (including next generation sequencing/NGS and genomic medicine), in vitro drug safety testing (also referred to as ADME/Tox), and molecular & protein biology.This approach ties together my earliest professional experiences including the strategic components I learned as a consultant at McKinsey & Co. and the operational components I learned as a Six Sigma Master Black Belt at Gateway Computers.I have been invited to speak at international conferences on personalized medicine, genomics, medical devices and other topics. I am passionate about genomics and other -omics technologies as a means to revolutionize healthcare and I believe that passion comes through in the talks I give.
Champions Oncology, Inc.
View- Website:
- championsoncology.com
- Employees:
- 185
-
Chief Executive OfficerChampions Oncology, Inc.Boston, Ma, Us
-
Executive Vice President And Chief Business OfficerVeracyte, Inc. Jul 2021 - PresentSouth San Francisco, Ca, UsVeracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world.Responsible for Corporate Development, Business Development, Strategy, M&A, Strategic Partnerships, and the company's Program Management Office (PMO). -
Member Board Of DirectorsChampions Oncology, Inc. Feb 2021 - PresentHackensack, New Jersey, UsChampions Oncology is a global preclinical research and clinical specialty testing provider driving excellence in oncology drug development programs.Serve on the Nominating and Governance committee.
-
Member Board Of DirectorsCode Ocean May 2024 - PresentNew York, Ny, UsCode Ocean is a privately held cloud-based computational science platform company: https://codeocean.com/about -
Member Board Of DirectorsChildren'S Tumor Foundation Sep 2015 - PresentNew York, Ny, UsThe Children’s Tumor Foundation is a 501(c)(3) not-for-profit organization dedicated to funding and driving innovative research that will result in effective treatments for the millions of people worldwide living with neurofibromatosis (NF), a term for three distinct disorders: NF1, NF2, and schwannomatosis.Serve on the Medical Advisory Committee and Business Advisory Committee -
Chief Executive OfficerGenuity Science Mar 2018 - Jan 2021Boston, Massachusetts, UsFormerly known as WuXi NextCODE and restructured into Genuity Science in June 2020. Company based in Shanghai, Cambridge (MA), Dublin and Reykjavik. Recognized by Fast Company as a "Most Innovative Company" in Biotech and by Business Intelligence Group with a "BIG Innovation Award".Genuity Science is focused on deriving insights from large-scale genomic data to improve healthcare. The company improves lives by partnering with Pharmaceutical and Biotech companies to leverage our advanced data science capabilities (including AI) to analyze genomic data and identify novel biological insights that catalyze meaningful discovery and more rapid development of transformative therapies.As CEO, I led the organization through significant revenue growth, and re-engineered the company strategy to focus the company on a coherent data and insights strategy targeted at the Pharmaceutical and Biotech market segments. This strategy pivot included (a) the acquisition of Genomics Medicine Ireland, (b) leading a Series C Fundraising Round, and (c) the launch of the Irish Precision Medicine Initiative. I also led a major corporate restructuring to ensure business continuity in response to changes in global genomic data regulations and changing global operating dynamics by separating our corporate entity into two companies: Genuity Science (ex-China) and Mingma (in China), reconstituting the Board, and other significant changes. -
Chief Operating OfficerGenuity Science Aug 2017 - Mar 2018Boston, Massachusetts, UsFunctional responsibility for all aspects of commercial (sales, marketing, customer engagement, service and support) and product strategy/management, as well as driving the internal business operations of the company globally, including within China. Business areas included a diagnostics business and launching a consumer product within China, a software platform for managing and analyzing large scale genomic data and clinically analyzing individual patients, serving population screening programs with our tools and analytical support.
-
Vp/Gm, Life Sciences & Applied GenomicsIllumina 2016 - Aug 2017San Diego, Ca, UsResponsibility for Product Marketing, Market Development, and Product Development for the Life Sciences, Consumer, Agrigenomics, Complex Genetic Diseases, Cell Biology, Microbiology, Forensics, and HLA markets, as well as the Array Platform, collectively accounting for >$1B in annual revenue. -
Vp, Arrays BusinessIllumina 2015 - 2016San Diego, Ca, UsResponsibility for Product Marketing, Market Development and Product Development for Illumina's Microarray Platform.
-
Vp/Gm, Enterprise Genomics SolutionsThermo Fisher Scientific 2013 - 2015Waltham, Ma, UsFollowing ThermoFisher's acquisition of Life Technologies, I led a business that partners with governments, foundations, thought leaders and global corporations to drive population-scale genetic analysis and transform the way that healthcare is practiced by accelerating discovery and bringing genomic medicine into the clinic. Responsible for all facets of the business with a primary focus on business development, international commercial activities, and actively managing Thermo Fisher’s role in large-scale collaborations with government and academic institutions to use genomics as a tool to promote better healthcare and personalized medicine, e.g. Saudi Human Genome Program and Stratified Medicine Scotland Innovation Centre. During my tenure as general manager, the business grew over 40% and 11 new large opportunities cumulatively valued at >$100M were added to the sales funnel. -
Head Of Molecular & Cell Biology Essentials Business And Vp/Gm, Molecular & Protein Biology BusinessLife Technologies Aug 2011 - Dec 2013Waltham, Ma, UsLed business for a broad ~$1.5B portfolio of mature life sciences tools for molecular, cell and protein biology in a heavily matrixed organization structure. A subsequent re-organization under a later Division President morphed that business leadership position into a formal GM role with more direct-line functional responsibility for the $750M subset of that portfolio related to molecular and protein biology. The business achieved or exceeded revenue plan and competitor index target during all full years of responsibility through multiple approaches, including key talent upgrades and the implementation of a detailed review of the product strategy for all 75+ product lines across the business using rigorous analytical frameworks. We also reinvigorated the product roadmap and doubled the product vitality index (percent of revenue coming from products introduced in the past 12 months), including the successful delivery and commercialization of multiple product development projects that each drove over $5M of revenue in their first year of sales.Based on results delivered and future potential, I was selected within Life Technologies as a ‘CEO designate’, a group of 10-12 high potential senior leaders identified as being on a C-suite trajectory and offered special development and mentorship opportunities. -
Vp/Gm, Cell Culture Essentials BusinessLife Technologies 2010 - 2011Waltham, Ma, UsServed as General Manager of a $230M research cell culture portfolio and charged with revitalizing the product portfolio. Achieved revenue plan and revamped the new product introduction pipeline to drive $3M of incremental ‘New Product’ revenue in the one year in the role. Multiple product development projects conceived and initiated in this timeframe subsequently achieved over $3M in their first year of launch.
-
Vp/Gm, In Vitro Adme/Tox BusinessLife Technologies 2008 - 2010Waltham, Ma, UsGeneral Manager of a wholly-owned subsidiary of Life Technologies. Appointed to replace CEO of a recently acquired company and grow a global ~$20M business with ~100 employees and 2 facilities. Partnered with CSO to turn a recently acquired business unit back toward profitability. Working with a group of senior scientists, I led the team that established, engineered, initiated and implemented the execution plan that subsequently led to profitability. That transformation almost doubled the products business during my tenure. Part of the growth came from initiatives to expand the business' reach into new geographies including the opening of a new lab and build-out of commercial resources, leading to ex-US growth of 37% in a globally declining market environment.
-
Vp, Business Operations And MarketingInvitrogen 2006 - 2008Led marketing efforts for one of Invitrogen’s two divisions; also ensured execution of the strategic agenda as the ‘Chief of Staff’ for the Division President. The Cell Culture Systems Division was a $400M+ division that grew 17% in 2008. As a part of this role, initiated and executed the first two years of a long-term share capture program in a large strategic product segment that ultimately led to ~5 points of share gain in that segment. -
Vp, Global Sales OperationsInvitrogen 2005 - 2006Waltham, Ma, UsResponsible for tools, processes and relationships to improve channel effectiveness, including negotiating agreements with key procurement personnel at various accounts and distribution partners. Included responsibility for the pricing team, sales force effectiveness, commercial integrations, and distributor management. While in this role, we drove a 1.5% increase in pricing performance over a 12-month period versus an annual operating plan that projected a decrease of 0.5% and I led negotiations that consummated a master supply agreement with a large pharmaceutical customer and a new distribution contract with a distributor for US Government customers, enabling access to new customers.
-
Sr. Director, Global ServicesInvitrogen 2004 - 2005Waltham, Ma, UsAs part of Commercial organization, responsible for a ~400 person Global Customer Care (Customer Service & Technical Support) organization and coordinating Invitrogen’s Custom Services business across multiple business units. While in this role, we drove 13% productivity in the Customer Service organization while improving service levels through talent management and revamping the hiring and training programs.Another aspect of this role was to design and build a Services Project Management Office to manage incoming custom service opportunities, with a focus on building the structure and hiring key talent to enable the build out. The net result led to ~8x growth over five years and a 30 point improvement in on-time reliability.
-
DirectorGateway 2000 - 2004Irvine, Ca, UsVarious Director level roles:Director, Software Business - $150M business segment leaderDirector, Customer Service and Support, Desktop Product LineDirector, Warranty & Excess MaterialsDirector, Corporate Initiatives - a series of assignments including Chief of Staff for the SVP of Operations (focused on manufacturing strategy and cost savings), Six Sigma Master Black Belt/Quality Director for Marketing and Sales, and Business Process Simplification (focused on reducing Supplier/Product SKU complexity)In these various roles, I drove initiatives that yielded over $500M of cumulative savings (e.g. drove a 50% reduction in YOY excess and obsolete materials costs, leading to $40 million in annual savings within 12 months and with processes/priorities in place to enable an additional 10% reduction in the following year). -
Management ConsultantMckinsey & Company 1997 - 2000Us
Rob Brainin Skills
Rob Brainin Education Details
-
Harvard Law SchoolJ.D. -
Emory UniversityEconomics
-
Rockville High School
Frequently Asked Questions about Rob Brainin
What company does Rob Brainin work for?
Rob Brainin works for Champions Oncology, Inc.
What is Rob Brainin's role at the current company?
Rob Brainin's current role is Chief Executive Officer.
What is Rob Brainin's email address?
Rob Brainin's email address is rb****@****ode.com
What is Rob Brainin's direct phone number?
Rob Brainin's direct phone number is +161771*****
What schools did Rob Brainin attend?
Rob Brainin attended Harvard Law School, Emory University, Rockville High School.
What skills is Rob Brainin known for?
Rob Brainin has skills like Biotechnology, Product Management, Management, Life Sciences, Lifesciences, Product Marketing, Cross Functional Team Leadership, Commercialization, Marketing Strategy, Leadership, Strategy, Genomics.
Who are Rob Brainin's colleagues?
Rob Brainin's colleagues are Scott Klug, Kalise Gilbert, Neil Gunn, Madison Weinberg, Simon Gunther, David Paraboschi, Alex Wang.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial